For an LRx prescription to be valid within the pre-index period in Italy, evidence of at least one preceding prescription within 15 months prior to the pre-index period was required to ensure patients were followed thoroughly
first occurrence of cardiovascular death, non-fatal stroke or non-fatal myocardial infarction) occurred in 12% of dulaglutide recipients (2.4 events per 100 person-years) and 13.4% of placebo recipients (2.7 events per 100 person-years, a hazard ratio of 0.88
Estos dos criterios fueron los objetivos principales del estudio, pero tambin se demostr una reduccin de la circunferencia de cintura, de la presin arterial sistlica y diastlica, del perfil glucmico, de la insulina en ayunas, del metabolismo lipdico De nuevo, los principales efectos adversos fueron gastrointestinales leves o moderadas, sobre todo al inicio o aumento de dosis, como se ha reportado en otros estudios previos con frmacos anlogos GLP-1
Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes, or type 2 diabetes: secondary analyses of pooled data from the SCALE Clinical Development Program
So, which supplements should you take while on GLP-1 medications to support your body properly
Record readings in the MeAgain app and note symptoms like palpitations or dizziness